EXHIBIT 10.2 DOE Patent License UNITED STATES DEPARTMENT OF ENERGY WASHINGTON, D.C. 2058 EXCLUSIVE PATENT LICENSE This Agreement made this 26 day of August, 2005, by and between the United States of America, as represented by the United States...Exclusive Patent License • August 30th, 2005 • HydroGen CORP • Engines & turbines
ContractExclusive Patent License • April 10th, 2020
This document is scheduled to be published in the Federal Register on 04/13/2020 and available online at federalregister.gov/d/2020-07707, and on govinfo.gov
EXCLUSIVE PATENT LICENSEExclusive Patent License • August 21st, 2007 • Teradata Corp /De/ • Computer storage devices
THIS EXCLUSIVE PATENT LICENSE (hereinafter “EPL”) is effective as of , by and between NCR Corporation, a Maryland corporation, having a principal place of business at 1700 S. Patterson Blvd., Dayton, Ohio 45479 (hereinafter “NCR”), and Teradata US, Inc., a Delaware corporation, having a principal place of business at 1700 S. Patterson Blvd., Dayton, Ohio 45479 (hereinafter “Teradata”), each hereinafter referred to as a “Party.”
EXCLUSIVE PATENT LICENSEExclusive Patent License • March 15th, 2011 • Imaging Diagnostic Systems Inc /Fl/ • Electromedical & electrotherapeutic apparatus
THIS LICENSE AGREEMENT made and entered into this 2nd day of June 1998 by and between Imaging Diagnostic Systems, Inc., a Florida Corporation "LICENSEE") and Richard Grable, an Individual ("GRABLE").
FIRST AMENDMENT TO THE EXCLUSIVE PATENT LICENSEExclusive Patent License • November 5th, 2020 • Solid Biosciences Inc. • Biological products, (no disgnostic substances)
This First Amendment dated as of October 9, 2020 (the “Amendment”) is made to that Exclusive Patent License between Solid Biosciences Inc. (“Solid”) and the University of Washington acting through UW CoMotion (“University”) dated as of October 16, 2015 with a University reference number 37475A (the “Agreement”). Capitalized terms used herein and not defined have the meaning as set forth in the Agreement.
MOMENTA PHARMACEUTICALS, INC. 675 WEST KENDALL STREET T: 617.491.9700 F: 617.621.0431Exclusive Patent License • August 9th, 2007 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances)
Reference is made to the Amended and Restated Exclusive Patent License between the Massachusetts Institute of Technology and Momenta Pharmaceuticals, Inc. dated November 1, 2002, as amended by a First Amendment dated November 15, 2002, letter agreements dated September 12, 2003 and October 22, 2003, a Second Amendment dated November 19, 2003, a Third Amendment dated April 2, 2004, a Fourth Amendment dated July 17, 2004, a Fifth Amendment dated August 5, 2006, a Sixth Amendment dated January 10, 2007 and letter agreements dated August 10, 2006 and October 18, 2006 (collectively, the “Agreement”). Capitalized terms used herein and not otherwise defined shall have the meanings given such terms in the Agreement.
AGREEMENTExclusive Patent License • January 12th, 2021
